FTIWX
Price
$13.99
Change
-$0.02 (-0.14%)
Updated
Aug 1 closing price
Net Assets
5.49B
GCFRX
Price
$9.91
Change
+$0.02 (+0.20%)
Updated
Aug 1 closing price
Net Assets
257.22M
Interact to see
Advertisement

FTIWX vs GCFRX

Header iconFTIWX vs GCFRX Comparison
Open Charts FTIWX vs GCFRXBanner chart's image
Fidelity Advisor Asset Manager 20% I
Price$13.99
Change-$0.02 (-0.14%)
VolumeN/A
Net Assets5.49B
Nationwide Inv Dest Cnsrv R
Price$9.91
Change+$0.02 (+0.20%)
VolumeN/A
Net Assets257.22M
FTIWX vs GCFRX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FTIWX vs. GCFRX commentary
Aug 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FTIWX is a Buy and GCFRX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FTIWX has more cash in the bank: 5.49B vs. GCFRX (257M). GCFRX (3.23) and FTIWX (3.17) have matching dividends . FTIWX was incepted earlier than GCFRX: FTIWX (19 years) vs GCFRX (22 years). GCFRX (1.18) is less costly to investors than FTIWX (0.52). GCFRX is a more actively managed with annual turnover of: 28.74 vs. FTIWX (24.00). FTIWX (0) and GCFRX (0) have matching initial minimum investment requirements. FTIWX annual gain was more profitable for investors over the last year : 6.09 vs. GCFRX (2.41). FTIWX return over 5 years is better than : 12.80 vs. GCFRX (6.75).
FTIWXGCFRXFTIWX / GCFRX
Total Expense Ratio0.521.1844%
Annual Report Gross Expense Ratio0.521.1844%
Fund Existence19 years22 years-
Gain YTD4.8073.947122%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRA500N/A-
Net Assets5.49B257M2,137%
Annual Yield % from dividends3.173.2398%
Returns for 1 year6.092.41253%
Returns for 3 years13.4210.15132%
Returns for 5 years12.806.75190%
Returns for 10 years28.4920.03142%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARKAF70.18N/A
N/A
Arkema
ORPEF14.22N/A
N/A
Orpea ACT
WZZAF15.95N/A
N/A
Wizz Air Holdings PLC
RTNTF74.71N/A
N/A
Rio Tinto Ltd.
INBP0.28N/A
-0.62%
Integrated BioPharma, Inc.